Improving Remyelination for Spinal Cord Injury
Research Grant Recipient: Arthur E. Warrington, PhD
Award Value: $248,686
Research Focus: Nervous system regeneration
From the Investigator:
A natural human antibody designed to enhance brain and spinal cord remyelination is presently in clinical trial in patients with multiple sclerosis. Many studies support the concept that patients with spinal cord injury would also benefit from improved myelination.